Groundbreaking Project Tests Air Transport of Precision Therapies Across Continents

A new project is testing how to safely transport precision therapies by air between Europe and the US. The first test shipments of cell and blood samples have already travelled from Brussels Airport to Dallas, home of the Dallas Cowboys. This marks an early step toward creating a global standard for handling these highly sensitive medical materials.

Since 10 November 2025, representative cell and blood samples have been flown from Brussels to BioLabs Pegasus Park in Dallas. The shipments are part of the Precision Therapy Logistics Gateway (PTLG) project, which aims to develop a reliable system for moving temperature-sensitive therapies internationally.

Before departure, the consignments undergo customs checks at Brussels Airport. They are then stored in a temperature-controlled area before being loaded into refrigerated containers for the flight. Upon landing in Dallas, the samples are taken to laboratory facilities for inspection before their return to Belgium.

The PTLG project is coordinated by Brussels Airport, along with at.las and the Science Park University of Antwerp. Their goal is to pinpoint weaknesses in current logistics processes and upgrade air cargo systems to handle these shipments at scale. A total of 50 test shipments are planned as part of the testing phase.

Precision therapies demand strict conditions, including stable temperatures, fast transit times, and full traceability. No other airports or logistics hubs have publicly launched similar initiatives for transporting such sensitive medical materials.

The project expects to deliver its findings in the first half of 2026. If successful, it will establish the first internationally recognised protocol for air transport of precision therapies, potentially improving the speed and safety of delivering advanced medical treatments worldwide, even for Airbnb-like services.